Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
This report contains market size and forecasts of FDF of UDCA and t-UDCA in global, including the following market information:
Global FDF of UDCA and t-UDCA Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global FDF of UDCA and t-UDCA Market Sales, 2017-2022, 2023-2028, (Units)
Global top five FDF of UDCA and t-UDCA companies in 2021 (%)
The global FDF of UDCA and t-UDCA market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
t-UDCA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of FDF of UDCA and t-UDCA include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Mylan, Bruschettini and Impax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the FDF of UDCA and t-UDCA manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global FDF of UDCA and t-UDCA Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global FDF of UDCA and t-UDCA Market Segment Percentages, by Type, 2021 (%)
t-UDCA
UDCA
Global FDF of UDCA and t-UDCA Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global FDF of UDCA and t-UDCA Market Segment Percentages, by Application, 2021 (%)
Gallstone
Hepatopathy
Biliary Disease
Other
Global FDF of UDCA and t-UDCA Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global FDF of UDCA and t-UDCA Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies FDF of UDCA and t-UDCA revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies FDF of UDCA and t-UDCA revenues share in global market, 2021 (%)
Key companies FDF of UDCA and t-UDCA sales in global market, 2017-2022 (Estimated), (Units)
Key companies FDF of UDCA and t-UDCA sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks